<p>Pharmacokinetic parameters of carfilzomib after the intravenous administration of polymeric micelle formulation containing carfilzomib (CFZ-PM) and cyclodextrin-based carfilzomib formulation (CFZ-CD) to ICR mice.</p
<p>Abbreviations:</p><p>t<sub>1/2</sub>: elimination half-life; AUC: area under the plasma drug conc...
<p>Pharmacokinetic properties of PF-01247324 dosed in C57BL6 mice (n = 3 per dose level).</p
<p>C<sub>max</sub>: peak plasma concentration; T<sub>max</sub>: time to peak plasma concentration; A...
<p>Data are shown as means ± S.D. (n = 4–5). The inset figures show the plasma concentration-time pr...
Carfilzomib (CFZ) is a peptide epoxyketone proteasome inhibitor approved for the treatment of multip...
Carfilzomib-loaded polymeric micelles (CFZ-PM) based on poly(ethylene glycol)-b-poly(N-2-benzoyloxyp...
<p>Pharmacokinetic and pharmacodynamic parameters of amoxicillin and cefquinome in mice after subcut...
Carfilzomib, an irreversible proteasome inhibitor, has a favorable safety profile and significant an...
Carfilzomib (CFZ) is a peptide epoxyketone proteasome inhibitor approved for the treatment of multip...
<p>* Cmax, maximum plasma concentration; Tmax, time to maximum plasma concentration; AUClast, area u...
<p>The Pharmacokinetic Parameters of Azithromycin in Normal Mice and LPS-Challenging Mice.</p
<p><sup>a</sup>p<0.05</p><p>Pharmacokinetic parameters of miltefosine after a single oral dose (10 m...
<p>The Pharmacokinetic Parameters of LPS in Normal Mice and Azithromycin-Treating Mice.</p
<p>Pharmacokinetic parameters for compound 4 and 5 based on oral administration in mice.</p
<p>Pharmacokinetic Parameters of Compounds <b>7c</b> and <b>7m</b> in Male ICR Mice.</p
<p>Abbreviations:</p><p>t<sub>1/2</sub>: elimination half-life; AUC: area under the plasma drug conc...
<p>Pharmacokinetic properties of PF-01247324 dosed in C57BL6 mice (n = 3 per dose level).</p
<p>C<sub>max</sub>: peak plasma concentration; T<sub>max</sub>: time to peak plasma concentration; A...
<p>Data are shown as means ± S.D. (n = 4–5). The inset figures show the plasma concentration-time pr...
Carfilzomib (CFZ) is a peptide epoxyketone proteasome inhibitor approved for the treatment of multip...
Carfilzomib-loaded polymeric micelles (CFZ-PM) based on poly(ethylene glycol)-b-poly(N-2-benzoyloxyp...
<p>Pharmacokinetic and pharmacodynamic parameters of amoxicillin and cefquinome in mice after subcut...
Carfilzomib, an irreversible proteasome inhibitor, has a favorable safety profile and significant an...
Carfilzomib (CFZ) is a peptide epoxyketone proteasome inhibitor approved for the treatment of multip...
<p>* Cmax, maximum plasma concentration; Tmax, time to maximum plasma concentration; AUClast, area u...
<p>The Pharmacokinetic Parameters of Azithromycin in Normal Mice and LPS-Challenging Mice.</p
<p><sup>a</sup>p<0.05</p><p>Pharmacokinetic parameters of miltefosine after a single oral dose (10 m...
<p>The Pharmacokinetic Parameters of LPS in Normal Mice and Azithromycin-Treating Mice.</p
<p>Pharmacokinetic parameters for compound 4 and 5 based on oral administration in mice.</p
<p>Pharmacokinetic Parameters of Compounds <b>7c</b> and <b>7m</b> in Male ICR Mice.</p
<p>Abbreviations:</p><p>t<sub>1/2</sub>: elimination half-life; AUC: area under the plasma drug conc...
<p>Pharmacokinetic properties of PF-01247324 dosed in C57BL6 mice (n = 3 per dose level).</p
<p>C<sub>max</sub>: peak plasma concentration; T<sub>max</sub>: time to peak plasma concentration; A...